Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation-Reference-Cited by-同舟云学术

Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation

Published:2004-05 Issue:5 Volume:10 Page:328-336
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Cutler Corey,Kim Haesook T,Hochberg Ephraim,Ho Vincent,Alyea Edwin,Lee Stephanie J,Fisher David C,Miklos David,Levin Jesse,Sonis Stephen,Soiffer Robert J,Antin Joseph H

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference63 articles.

1. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia;Storb;Blood,1989

2. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation;Champlin;Blood,2000

3. Effect of rapamycin on the cyclosporin A-resistant CD28-mediated costimulatory pathway;Ghosh;Blood,2002

4. Molecular actions of sirolimus;Kirken;Transplant Proc,2003

5. Rapamune (RAPA, rapamycin, sirolimus);Sehgal;Clin Biochem,1998

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autophagy differentially regulates tissue tolerance of distinct target organs in graft-versus-host disease models;Journal of Clinical Investigation;2024-03-01

2. Chronic GVHD: review advances in prevention, novel endpoints, and targeted strategies;Hematology;2023-12-08

3. Outcome improvement over time in reduced intensity conditioning hematopoietic transplantation: a 20-year experience;Annals of Hematology;2023-11-16

4. The delicate balance of graft versus leukemia and graft versus host disease after allogeneic hematopoietic stem cell transplantation;Expert Review of Hematology;2023-11-06

5. Effect of mTOR Inhibition with Sirolimus on Natural Killer Cell Reconstitution in Allogeneic Stem Cell Transplantation;Transplantation and Cellular Therapy;2023-06